• 药物临床观察 • 上一篇    下一篇

倍美力与米非司酮和米索配伍治疗稽留流产

涂红勤   

  1. 武汉市妇女儿童医疗保健中心 妇产科
  • 收稿日期:2012-02-11 修回日期:2012-06-20 出版日期:2013-01-15 发布日期:2013-01-15
  • 通讯作者: 涂红勤

the treatment of the viscera abortion in compatibility of premarin 、 mifepristone and misoprostol

  • Received:2012-02-11 Revised:2012-06-20 Published:2013-01-15 Online:2013-01-15

摘要:

【摘要】 <正>稽留流产是临床上处理较困难的一种流产类型。造成稽留流产的原因有染色体的数量或结构异常、子宫内环境异常、内分泌功能紊乱、免疫功能不全、过量吸烟、全身感染疾病及严重营养缺乏等。目前,其发生机制尚不明确,可能是多因素共同作用的结果[1]。我院采用结合雌激素片(倍美力,爱尔兰惠氏药厂)与米非司酮、米索前列醇(北京紫竹药业有限公司)配伍治疗稽留流产,取得较满意的效果,报告如下。 

关键词:  米非司酮, 米索前列醇, 倍美力, 稽留流产

Abstract: 【 Abstract 】 Objective To study the treatment of the viscera abortion in compatibility of premarin 、 mifepristone and misoprostol use in order to improve the success rate of miscarriage, reduce the role of the bleeding. Method 76 cases were randomly divided into application viscera abortion which only used mifepristone and misoprostol get medicine flow (control group) and prepared with premarin medicine flow (the observation group), two groups of patients medicine flow success rate, blood loss, etc are compared. Result The observation group operation flow rate, traditional medicine with reduced blood loss was better than control. Conclusion the compatibility with mifepristone influences misoprostol treatment can speed up the natural emptying viscera miscarriage embryo organization and shorten the time abortion completely after miscarriage bleeding time.

Key words: mifepristone, misoprostol, premarin, viscera abortion